В администрировании и научных исследованиях можно встретить людей, чьи успехи и мотивация по-настоящему формируют облик перспективных технологий будущего. Поэтому еще одной задачей проекта BioDARPA является внимание к успехам и оригинальным идеям и действиям совершенно небольшой группы людей (не более 54 человек) - государственных чиновников, руководителей лабораторий, R&D-сотрудников корпораций и аналитиков НКО.
В совокупности эти люди составляют обойму лиц принимающих решения в отношении облика будущего. Возможность работы с ними, изучение их мотивации, помощь и привлечение в совместные проекты может стать одним из ключевых факторов "ускорения времени" в этой значимой области.
Д-р Джеффри Лин, M.D., Ph.D., перешел в DARPA с позиции преподавателя и врио главы Отдела неврологии Объединенного университета медицинских наук (USUHS). Д-р Лин получил свою докторскую степень в области фармакологии по окончании аспирантуры Школы медицинских наук Корнелльского университета, а медицинскую степень в Джорджтаунском университете. Д-р Лин прошел свою последипломную больничную подготовку (резидентуру) по неврологии в Центральном армейском госпитале им. Уолтера Рида, занимался исследовательской работой в области нейрофармакологии в Онкологическом центре Слоан-Кеттеринг и завершил аспирантуру по неврологии в Больнице Джонса Хопкинса. На сегодняний день в дополнение к работе по программам DARPA он работает неврологом интенсивной терапии в Больнице Джонса Хопкинса.
Д-р Лин отслужил 27 лет в военно-медицинской службе Армии США, включая командировки в Афганистан (2003) и Ирак (2005), и четыре посещения ТВД в составе комиссии Председателя Объединенного комитета начальников штабов по контролю результатов терапии травм головного мозга военнослужащих. Он уволился из армии в 2012 году в звании полковника.
Д-р Лин опубликовал больше чем 150 статей в рецензируемых журналах, обзоры и главы в книгах. Он - член Американской неврологической ассоциации, почетный член Американской академии неврологии, Общества неврологической интенсивной терапии и Общества неврологии.
Научные интересы д-ра Лина сосредоточены на диагностике и разработке терапевтических ответов при травмах головного и спинного мозга.
Под его руководством находятся следующие программы DARPA:
Battlefield Medicine
Fracture Putty
Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR)
Д-р Алисия Джексон пришла на работу в DARPA в октябре 2010 года. Ее научные интересы включают интеграцию инженерных наук с биологией для разработки и сборки живых клеток и неорганических материалов, создания новых производственных процессов повышенной адаптивности и стойкости к условиям боевой обстановки, и технологий биологического производства самовосстанавливающихся материалов, с целью создания технологий расширения их производства и наоборот - создания способов производства "нетехнологичных" материалов.
Д-р Джексон пришла в DARPA из Комитета по энергетическим и природным ресурсам Сената США, где она проходила службу в качестве специалиста. Опыт работы включает проекты "Умные энергетические сети (Smart Grid)", "Масштабное аккумулирование электроэнергии энергосетей", "Национальная конкурентоспособность", "Рабочие места в отрасли экологически чистой энергетики" и "Федеральные НИОКР в области энергетики".
Под ее руководством находятся следующие программы DARPA:
Living Foundries
Mr. Jason Lamp
Assistant Director, Program Management
Biological Technologies Office phillip.lamp@darpa.mil
М-р Джейсон Лэмп является помощником начальника Отдела биологических технологий DARPA.
Г-жа Лайза Мэттокс является аналитиком программ в Отделе биологических технологий. До прихода в DARPA она служила Представителем заказчика / Руководителем отделения поддержки DARPA во внутреннем департаменте Национального Бизнес-центра в Аризоне.
Г-жа Мэттокс имеет образование бакалавра гуманитарных наук в области образования и получает магистерскую степень в области менеджмента в Баптистском Университете Уэйленд.
Bio
Dr. Casebeer's research interests include neuroethics, the evolution of morality, the intersections of cognitive science and national security policy, philosophy of mind and military ethics (such as the ethics of torture interrogation).
He is author of Natural Ethical Facts: Evolution, Connectionism, and Moral Cognition (MIT Press), co-author of Warlords Rising: Confronting Violent Non-State Actors (Lexington Books), and has published on topics ranging from the morality of torture interrogation to the rhetoric of evil in international relations, in venues such as Nature Reviews Neuroscience, Biology and Philosophy, and International Studies. He is a reviewer for multiple academic presses and journals and has conducted numerous refereed conference presentations. Before joining DARPA, Dr. Casebeer was the Deputy Head of the Joint Warfare Analysis Center’s Technology Advancement Department. His most recent intelligence assignment was as the Chief of Eurasian Intelligence Analysis, NATO Military Headquarters.
PROGRAMS
Narrative Networks
Strategic Social Interaction Modules (SSIM) Young Faculty
Bio
Dr. Mildred Donlon manages research programs developing advanced chemical and biological detectors for battlefield, counter proliferation, and intelligence applications.
Donlon received her Master of Science in radiation biology and biophysics and her doctorate in microbiology and immunology from the University of Rochester.
She has been serving the Department of Defense in the development of nuclear, chemical and biological technology since 1973. In April 1992, she was presented the Defense Nuclear Agency's highest civilian award, the Exceptional Civilian Service Medal, for her contributions to DSWA.
Among her contributions to the Department of Defense: Chairperson for the Legislative and Implementation Subpanels OSD Laboratory Demonstration Program, Defense Management Review (1991-1993); Chairperson of the Non-proliferation and Arms Control Technology Working Group (TWG) (Chemical Weapons Focus Group) (1995-1996); and, Member, American Society for Microbiology; Task Force on Biological Weapons (1996-present).
Bio
Dr. Justin Gallivan joined the Defense Advanced Research Projects Agency in January 2014. He is interested in many facets of synthetic biology, including engineering microbial communities to produce small molecules or to prevent disease, and reprogramming multicellular organisms to perform complex tasks.
Dr. Gallivan came to DARPA from Emory University, where he was an Associate Professor and a Winship Distinguished Research Professor in the Department of Chemistry. At Emory, he led a research program in RNA-based synthetic biology.
Dr. Gallivan received a Bachelor of Science in Chemistry from the University of Illinois at Urbana-Champaign (1994) and a Doctor of Philosophy in Chemistry from the California Institute of Technology (2000), where he later completed a National Institutes of Health National Research Service Award postdoctoral fellowship. He has been a Fellow of the Alfred P. Sloan Foundation, a Camille Dreyfus Teacher-Scholar, a Beckman Young Investigator and a PopTech Science and Public Leadership Fellow.
LTC Matthew Hepburn, MC, USA
Program Manager
Biological Technologies Office matthew.hepburn@darpa.mil
Bio
Lieutenant Colonel (P) Matthew Hepburn, MC, USA joined DARPA as a program manager in 2013. He aims to address the dynamic threats of emerging infectious diseases with potential impact on national security.
Prior to joining DARPA, LTC(P) Hepburn served as the Director of Medical Preparedness on the White House National Security Staff. Additional previous assignments include: Chief Medical Officer at a Level II medical facility in Iraq, clinical research director at the US Army Medical Research Institute for Infectious Diseases, exchange officer to the United Kingdom and internal medicine chief of residents at Brooke Army Medical Center at Fort Sam Houston, Texas.
LTC(P) Hepburn completed internal medicine residency and infectious diseases fellowship programs at Brooke Army Medical Center. He holds Doctor of Medicine and Bachelor of Science in biomedical engineering degrees from Duke University.
PROGRAMS
Prophecy (Pathogen Defeat)
Wound Stasis System (WSS)
Bio
Dr. Barry Pallotta joined DARPA as a program manager in 2011. His interests focus on complex biological systems and their application to scientific discovery and the development of medical countermeasures to biological threats.
Prior to joining the Defense Sciences Office at DARPA, Dr. Pallotta was a member of the research staff at the Institute for Defense Analyses in Alexandria, Virginia. From 1983 to 2001, Dr. Pallotta was on the faculty of the University of North Carolina School of Medicine at Chapel Hill.
He holds a Bachelor of Science in physics from the State University of New York at Stony Brook and a Doctor of Philosophy in Physiology and Biophysics from the University of Vermont.
PROGRAMS
Microphysiological Systems
Rapid Threat Assessment
Bio
Dr. Justin Sanchez joined DARPA as a program manager in 2013 to explore neurotechnology, brain science and systems neurobiology.
Before coming to DARPA, Dr. Sanchez was an Associate Professor of Biomedical Engineering and Neuroscience at the University of Miami, and a faculty member of the Miami Project to Cure Paralysis. He directed the Neuroprosthetics Research Group, where he oversaw development of neural-interface medical treatments and neurotechnology for treating paralysis and stroke, and for deep brain stimulation for movement disorders, Tourette’s syndrome and Obsessive-Compulsive Disorder.
Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans where he studied the activity of single neurons, local field potentials and electrocorticogram in the cerebral cortex and from deep brain structures of the motor and limbic system.
He is an elected member of the Administrative Committee of the IEEE Engineering in Medicine and Biology Society.
He has published more than 75 peer-reviewed papers, holds seven patents in neuroprosthetic design and authored a book on the design of brain-machine interfaces. He has served as a reviewer for the NIH Neurotechnology Study Section, DoD’s Spinal Cord Injury Research Program and the Wellcome Trust, and as an associate editor of multiple journals of biomedical engineering and neurophysiology.
Dr. Sanchez holds Doctor of Philosophy and Master of Engineering degrees in Biomedical Engineering, and a Bachelor of Science degree in Engineering Science, all from the University of Florida.
PROGRAMS
Enabling Stress Resistance
Neuro Function, Activity, Structure, and Technology (Neuro-FAST)
Restoring Active Memory (RAM)
Revolutionizing Prosthetics
Systems-Based Neurotechnology for Emerging Therapies (SUBNETS)
Lt Col Daniel J. Wattendorf, MC, USAF
Program Manager
Biological Technologies Office daniel.wattendorf@darpa.mil
Bio
Lt Col Daniel J. Wattendorf, MC, USAF, joined DARPA as a Program Manager in the Defense Sciences Office in 2010. His interests focus on applying methodological advances in genomics and biotechnology to optimize health and prevent disease—specifically to achieve simple solutions that improve health care at the point-of-care, anywhere.
He holds a Bachelor of Science in microbiology from Cornell University and a medical degree with distinction from George Washington University. He completed a residency in family medicine at the National Capital Consortium; a residency in clinical genetics at the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH); a fellowship in clinical cytogenetics at Georgetown University; and a fellowship in health policy from the Office of the Director, NHGRI, NIH. Lt Col Wattendorf previously served as Director, Air Force Medical Genetics Center and program manager for an Advanced Concept Technology Demonstration integrating advanced diagnostics and informatics with surveillance systems to rapidly detect natural and hostile pathogens in the Office of the Air Force Surgeon General. In addition to his DARPA programs, he is a geneticist at the National Naval Medical Center and the Cancer Genetics Branch, National Cancer Institute, NIH.
PROGRAMS
Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT)
Surviving Blood Loss (SBL)
Bio
Dr. Doug Weber joined DARPA as a Program Manager in 2013.
His research interests are in the field of neural engineering, specifically: neural interface systems and how to apply these technologies to acquiring and decoding neural signals for controlling assistive and prosthetic devices; and neural stimulation technologies for restoring or retraining sensory, motor and autonomic functions.
Dr. Weber came to DARPA from the University of Pittsburgh, where he was an Associate Professor in the Department of Bioengineering and the Department of Physical Medicine and Rehabilitation. He also served the U.S. Department of Veterans Affairs (VA) as a Research Biomedical Engineer in the VA Pittsburgh Health System.
Dr. Weber is a member of the Society for Neuroscience and a senior member of the Institute for Electrical and Electronics Engineers. He has published extensively in peer-reviewed journals and has mentored several undergraduate and graduate students in bioengineering, medical students and postdoctoral fellows.
He holds a Bachelor of Science degree in Biomedical Engineering from the Milwaukee School of Engineering and Master of Science and Doctor of Philosophy degrees in Bioengineering from Arizona State University. He completed post-doctoral training in the Centre for Neuroscience at the University of Alberta.
В совокупности эти люди составляют обойму лиц принимающих решения в отношении облика будущего. Возможность работы с ними, изучение их мотивации, помощь и привлечение в совместные проекты может стать одним из ключевых факторов "ускорения времени" в этой значимой области.
Dr. Geoffrey Ling
Office Director
Biological Technologies Office
geoffrey.ling@darpa.mil
Д-р Лин отслужил 27 лет в военно-медицинской службе Армии США, включая командировки в Афганистан (2003) и Ирак (2005), и четыре посещения ТВД в составе комиссии Председателя Объединенного комитета начальников штабов по контролю результатов терапии травм головного мозга военнослужащих. Он уволился из армии в 2012 году в звании полковника.
Д-р Лин опубликовал больше чем 150 статей в рецензируемых журналах, обзоры и главы в книгах. Он - член Американской неврологической ассоциации, почетный член Американской академии неврологии, Общества неврологической интенсивной терапии и Общества неврологии.
Научные интересы д-ра Лина сосредоточены на диагностике и разработке терапевтических ответов при травмах головного и спинного мозга.
Под его руководством находятся следующие программы DARPA:
Dr. Alicia Jackson
Deputy Director
Biological Technologies Office
alicia.jackson@darpa.mil
Д-р Джексон пришла в DARPA из Комитета по энергетическим и природным ресурсам Сената США, где она проходила службу в качестве специалиста. Опыт работы включает проекты "Умные энергетические сети (Smart Grid)", "Масштабное аккумулирование электроэнергии энергосетей", "Национальная конкурентоспособность", "Рабочие места в отрасли экологически чистой энергетики" и "Федеральные НИОКР в области энергетики".
Под ее руководством находятся следующие программы DARPA:
Assistant Director, Program Management
Biological Technologies Office
phillip.lamp@darpa.mil
Program Analyst
Biological Technologies Office
lisa.mattocks@darpa.mil
Г-жа Мэттокс имеет образование бакалавра гуманитарных наук в области образования и получает магистерскую степень в области менеджмента в Баптистском Университете Уэйленд.
Program Manager
Biological Technologies Office
william.casebeer@darpa.mil
Dr. Casebeer's research interests include neuroethics, the evolution of morality, the intersections of cognitive science and national security policy, philosophy of mind and military ethics (such as the ethics of torture interrogation).
He is author of Natural Ethical Facts: Evolution, Connectionism, and Moral Cognition (MIT Press), co-author of Warlords Rising: Confronting Violent Non-State Actors (Lexington Books), and has published on topics ranging from the morality of torture interrogation to the rhetoric of evil in international relations, in venues such as Nature Reviews Neuroscience, Biology and Philosophy, and International Studies. He is a reviewer for multiple academic presses and journals and has conducted numerous refereed conference presentations.
Before joining DARPA, Dr. Casebeer was the Deputy Head of the Joint Warfare Analysis Center’s Technology Advancement Department. His most recent intelligence assignment was as the Chief of Eurasian Intelligence Analysis, NATO Military Headquarters.
PROGRAMS
Narrative Networks
Strategic Social Interaction Modules (SSIM)
Young Faculty
Program Manager
Biological Technologies Office
mildred.donlon@darpa.mil
Dr. Mildred Donlon manages research programs developing advanced chemical and biological detectors for battlefield, counter proliferation, and intelligence applications.
Donlon received her Master of Science in radiation biology and biophysics and her doctorate in microbiology and immunology from the University of Rochester.
She has been serving the Department of Defense in the development of nuclear, chemical and biological technology since 1973. In April 1992, she was presented the Defense Nuclear Agency's highest civilian award, the Exceptional Civilian Service Medal, for her contributions to DSWA.
Among her contributions to the Department of Defense: Chairperson for the Legislative and Implementation Subpanels OSD Laboratory Demonstration Program, Defense Management Review (1991-1993); Chairperson of the Non-proliferation and Arms Control Technology Working Group (TWG) (Chemical Weapons Focus Group) (1995-1996); and, Member, American Society for Microbiology; Task Force on Biological Weapons (1996-present).
Program Manager
Biological Technologies Office
justin.gallivan@darpa.mil
Dr. Justin Gallivan joined the Defense Advanced Research Projects Agency in January 2014. He is interested in many facets of synthetic biology, including engineering microbial communities to produce small molecules or to prevent disease, and reprogramming multicellular organisms to perform complex tasks.
Dr. Gallivan came to DARPA from Emory University, where he was an Associate Professor and a Winship Distinguished Research Professor in the Department of Chemistry. At Emory, he led a research program in RNA-based synthetic biology.
Dr. Gallivan received a Bachelor of Science in Chemistry from the University of Illinois at Urbana-Champaign (1994) and a Doctor of Philosophy in Chemistry from the California Institute of Technology (2000), where he later completed a National Institutes of Health National Research Service Award postdoctoral fellowship. He has been a Fellow of the Alfred P. Sloan Foundation, a Camille Dreyfus Teacher-Scholar, a Beckman Young Investigator and a PopTech Science and Public Leadership Fellow.
Program Manager
Biological Technologies Office
matthew.hepburn@darpa.mil
Lieutenant Colonel (P) Matthew Hepburn, MC, USA joined DARPA as a program manager in 2013. He aims to address the dynamic threats of emerging infectious diseases with potential impact on national security.
Prior to joining DARPA, LTC(P) Hepburn served as the Director of Medical Preparedness on the White House National Security Staff. Additional previous assignments include: Chief Medical Officer at a Level II medical facility in Iraq, clinical research director at the US Army Medical Research Institute for Infectious Diseases, exchange officer to the United Kingdom and internal medicine chief of residents at Brooke Army Medical Center at Fort Sam Houston, Texas.
LTC(P) Hepburn completed internal medicine residency and infectious diseases fellowship programs at Brooke Army Medical Center. He holds Doctor of Medicine and Bachelor of Science in biomedical engineering degrees from Duke University.
PROGRAMS
Prophecy (Pathogen Defeat)
Wound Stasis System (WSS)
Biological Technologies Office
barry.pallotta@darpa.mil
Dr. Barry Pallotta joined DARPA as a program manager in 2011. His interests focus on complex biological systems and their application to scientific discovery and the development of medical countermeasures to biological threats.
Prior to joining the Defense Sciences Office at DARPA, Dr. Pallotta was a member of the research staff at the Institute for Defense Analyses in Alexandria, Virginia. From 1983 to 2001, Dr. Pallotta was on the faculty of the University of North Carolina School of Medicine at Chapel Hill.
He holds a Bachelor of Science in physics from the State University of New York at Stony Brook and a Doctor of Philosophy in Physiology and Biophysics from the University of Vermont.
PROGRAMS
Microphysiological Systems
Rapid Threat Assessment
Program Manager
Biological Technologies Office
justin.sanchez@darpa.mil
Dr. Justin Sanchez joined DARPA as a program manager in 2013 to explore neurotechnology, brain science and systems neurobiology.
Before coming to DARPA, Dr. Sanchez was an Associate Professor of Biomedical Engineering and Neuroscience at the University of Miami, and a faculty member of the Miami Project to Cure Paralysis. He directed the Neuroprosthetics Research Group, where he oversaw development of neural-interface medical treatments and neurotechnology for treating paralysis and stroke, and for deep brain stimulation for movement disorders, Tourette’s syndrome and Obsessive-Compulsive Disorder.
Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans where he studied the activity of single neurons, local field potentials and electrocorticogram in the cerebral cortex and from deep brain structures of the motor and limbic system.
He is an elected member of the Administrative Committee of the IEEE Engineering in Medicine and Biology Society.
He has published more than 75 peer-reviewed papers, holds seven patents in neuroprosthetic design and authored a book on the design of brain-machine interfaces. He has served as a reviewer for the NIH Neurotechnology Study Section, DoD’s Spinal Cord Injury Research Program and the Wellcome Trust, and as an associate editor of multiple journals of biomedical engineering and neurophysiology.
Dr. Sanchez holds Doctor of Philosophy and Master of Engineering degrees in Biomedical Engineering, and a Bachelor of Science degree in Engineering Science, all from the University of Florida.
PROGRAMS
Enabling Stress Resistance
Neuro Function, Activity, Structure, and Technology (Neuro-FAST)
Restoring Active Memory (RAM)
Revolutionizing Prosthetics
Systems-Based Neurotechnology for Emerging Therapies (SUBNETS)
Program Manager
Biological Technologies Office
daniel.wattendorf@darpa.mil
Lt Col Daniel J. Wattendorf, MC, USAF, joined DARPA as a Program Manager in the Defense Sciences Office in 2010. His interests focus on applying methodological advances in genomics and biotechnology to optimize health and prevent disease—specifically to achieve simple solutions that improve health care at the point-of-care, anywhere.
He holds a Bachelor of Science in microbiology from Cornell University and a medical degree with distinction from George Washington University. He completed a residency in family medicine at the National Capital Consortium; a residency in clinical genetics at the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH); a fellowship in clinical cytogenetics at Georgetown University; and a fellowship in health policy from the Office of the Director, NHGRI, NIH. Lt Col Wattendorf previously served as Director, Air Force Medical Genetics Center and program manager for an Advanced Concept Technology Demonstration integrating advanced diagnostics and informatics with surveillance systems to rapidly detect natural and hostile pathogens in the Office of the Air Force Surgeon General. In addition to his DARPA programs, he is a geneticist at the National Naval Medical Center and the Cancer Genetics Branch, National Cancer Institute, NIH.
PROGRAMS
Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT)
Surviving Blood Loss (SBL)
Program Manager
Biological Technologies Office
douglas.weber@darpa.mil
Dr. Doug Weber joined DARPA as a Program Manager in 2013.
His research interests are in the field of neural engineering, specifically: neural interface systems and how to apply these technologies to acquiring and decoding neural signals for controlling assistive and prosthetic devices; and neural stimulation technologies for restoring or retraining sensory, motor and autonomic functions.
Dr. Weber came to DARPA from the University of Pittsburgh, where he was an Associate Professor in the Department of Bioengineering and the Department of Physical Medicine and Rehabilitation. He also served the U.S. Department of Veterans Affairs (VA) as a Research Biomedical Engineer in the VA Pittsburgh Health System.
Dr. Weber is a member of the Society for Neuroscience and a senior member of the Institute for Electrical and Electronics Engineers. He has published extensively in peer-reviewed journals and has mentored several undergraduate and graduate students in bioengineering, medical students and postdoctoral fellows.
He holds a Bachelor of Science degree in Biomedical Engineering from the Milwaukee School of Engineering and Master of Science and Doctor of Philosophy degrees in Bioengineering from Arizona State University. He completed post-doctoral training in the Centre for Neuroscience at the University of Alberta.